News Heater
  • Home
  • Stock Ideas
    • Morning Brief
    • Analyst Insight
    • Equity Research
  • About Newsheater
    • Authors
    • Contact Us
  • Privacy Policy
No Result
View All Result
  • Home
  • Stock Ideas
    • Morning Brief
    • Analyst Insight
    • Equity Research
  • About Newsheater
    • Authors
    • Contact Us
  • Privacy Policy
News Heater
No Result
View All Result
Home Trending

Aptose Biosciences Inc. (APTO) Just Got Our Attention

by Daisy Galbraith
January 13, 2021
in Trending
0
Share on FacebookShare on Twitter

Aptose Biosciences Inc. (NASDAQ:APTO) went down by -4.49% from its latest closing price compared to the recent 1-year high of $9.25. The company’s stock price has collected -0.67% of loss in the last five trading sessions. Press Release reported on 12/06/20 that Aptose Presents Highlights from ASH and Corporate Update Event

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Is It Worth Investing in Aptose Biosciences Inc. (NASDAQ :APTO) Right Now?

Plus, the 36-month beta value for APTO is at 1.75. Opinions of the stock are interesting as 8 analysts out of 8 who provided ratings for Aptose Biosciences Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

Related articles

Why Platinum Group Metals Ltd. (PLG)’s Most Recent Report Reveals Some Hints About Its Future

January 19, 2021

Is There a Dimmer Outlook Ahead for Viking Therapeutics Inc. (VKTX)?

January 18, 2021

The average price from analysts is $10.38, which is $0.25 above the current price. APTO currently public float of 84.34M and currently shorts hold a 5.57% ratio of that float. Today, the average trading volume of APTO was 1.62M shares.

APTO’s Market Performance

APTO stocks went down by -0.67% for the week, with a monthly jump of 4.93% and a quarterly performance of -25.50%, while its annual performance rate touched -24.11%. The volatility ratio for the week stands at 5.73% while the volatility levels for the past 30 days are set at 5.71% for Aptose Biosciences Inc.. The simple moving average for the period of the last 20 days is 4.59% for APTO stocks with a simple moving average of -24.59% for the last 200 days.

Analysts’ Opinion of APTO

Many brokerage firms have already submitted their reports for APTO stocks, with Cantor Fitzgerald repeating the rating for APTO by listing it as a “Overweight.” The predicted price for APTO in the upcoming period, according to Cantor Fitzgerald is $10 based on the research report published on October 19th of the previous year 2020.

Alliance Global Partners, on the other hand, stated in their research note that they expect to see APTO reach a price target of $12. The rating they have provided for APTO stocks is “Buy” according to the report published on September 22nd, 2020.

Maxim Group gave a rating of “Buy” to APTO, setting the target price at $16 in the report published on February 20th of the previous year.

APTO Trading at -9.89% from the 50-Day Moving Average

After a stumble in the market that brought APTO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -51.69% of loss for the given period.

Volatility was left at 5.71%, however, over the last 30 days, the volatility rate increased by 5.73%, as shares surge +9.02% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -2.83% lower at present.

During the last 5 trading sessions, APTO fell by -0.67%, which changed the moving average for the period of 200-days by -25.38% in comparison to the 20-day moving average, which settled at $4.29. In addition, Aptose Biosciences Inc. saw 2.05% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at APTO starting from Whitehead Warren, who sale 20,000 shares at the price of $4.06 back on Dec 22. After this action, Whitehead Warren now owns 40,000 shares of Aptose Biosciences Inc., valued at $81,200 using the latest closing price.

Chow Gregory K., the Executive VP & CFO of Aptose Biosciences Inc., sale 126,668 shares at $6.05 during a trade that took place back on Jul 10, which means that Chow Gregory K. is holding 232,846 shares at $766,341 based on the most recent closing price.

Stock Fundamentals for APTO

The total capital return value is set at -49.84, while invested capital returns managed to touch -48.99. Equity return is now at value -49.50, with -46.60 for asset returns.

Based on Aptose Biosciences Inc. (APTO), the company’s capital structure generated 1.63 points at debt to equity in total, while total debt to capital is 1.60. Total debt to assets is 1.52, with long-term debt to equity ratio resting at 1.08. Finally, the long-term debt to capital ratio is 1.06.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

The liquidity ratio also appears to be rather interesting for investors as it stands at 17.83.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Tags: APTOAPTO stockAptose Biosciences Inc.NASDAQ:APTO
Share77Tweet48

Related Posts

Why Platinum Group Metals Ltd. (PLG)’s Most Recent Report Reveals Some Hints About Its Future

by Melissa Arnold
January 19, 2021
0

Platinum Group Metals Ltd. (AMEX:PLG) went down by -9.03% from its latest closing price compared to the recent 1-year high...

Is There a Dimmer Outlook Ahead for Viking Therapeutics Inc. (VKTX)?

by Daisy Galbraith
January 18, 2021
0

Viking Therapeutics Inc. (NASDAQ:VKTX) went down by -2.70% from its latest closing price compared to the recent 1-year high of...

Load More
  • Trending
  • Comments
  • Latest

Business Model Helped NIO Stock Add 11 Times To Its Value This Year

November 13, 2020

XL Fleet Corp. (XL) upgraded Issued by Wall Street Gurus

January 12, 2021

Why Enbridge Inc. (ENB)’s Most Recent Report Reveals Some Hints About Its Future

January 13, 2021

Why Applied DNA Sciences Inc. (APDN)’s Most Recent Report Reveals Some Hints About Its Future

January 11, 2021

4 Stocks to Watch Today…

0

A $2 5G Picks and Shovels Company with Bullish Momentum…

0

These 4 Stocks are ready to move!

0

4 Stocks to Watch on Tuesday…

0

Sealed Air Corporation (SEE): Skating on Thin Ice? We Know the Answer

January 19, 2021

Is U.S. Silica Holdings Inc. (SLCA) a Keeper?

January 19, 2021

Why Platinum Group Metals Ltd. (PLG)’s Most Recent Report Reveals Some Hints About Its Future

January 19, 2021

Cryoport Inc. (CYRX) Reveals an Earnings Mystery

January 19, 2021

News Heater

News Heater is specialized on the investments in tech sphere. Its specialists are interested in stocks that have been undervalued by different reasons. They are trying to find them, count their potential and bring them to their clients.

Categories

  • Analyst Insight
  • Business
  • Companies
  • Equity Research
  • Hot Stocks
  • Morning Brief
  • Stock Ideas
  • Trending
  • Uncategorized

Tags

AT&T Inc. Boston Scientific Corporation BSX BSX stock BYND BYND stock Carnival Corporation & Plc Discovery Inc. Exxon Mobil Corporation F FCX Ford Motor Company Fox Corporation F stock Inc JPM JPMorgan Chase & Co. JPM stock KDP KDP stock Keurig Dr Pepper Inc. Moderna Inc. MRNA stock NASDAQ:BYND NASDAQ:QCOM NYSE:BSX NYSE:F NYSE:JPM NYSE:T NYSE:WFC NYSE:XOM PFE stock QCOM QCOM stock QUALCOMM Incorporated T T stock UBER Under Armour Inc. WFC WFC stock WTI XOM XOM stock Zillow Group Inc.

Newsletter

Coming Soon

  • Home
  • About Newsheater
  • Privacy Policy
  • Contact Us

© 2021 Newsheater

No Result
View All Result
  • Homepages
  • Business

© 2020 Newsheater.com

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

236632
236633
236634